Jiang Dong-Jing, Zhang Li, Cao Yu-Dan, Yao Wei-Feng
Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Zhongguo Zhong Yao Za Zhi. 2016 Sep;41(17):3218-3225. doi: 10.4268/cjcmm20161716.
This article summarizes the research progress in recent years on interactions between Chinese medicines and gut microbiota based on the physiological functions of gut microbiota, including imbalance impacts of toxic/irritating Chinese medicines on gut microbiota, prognosis effects of Chinese medicines on gut microbiota imbalance, metabolism effects of gut microbiota on Chinese medicine components, and co-metabolism effects between gut microbiota and host. We would think and prospect the specific biological effects of Chinese medicines, gut microbiota structures and the relations between endogenous metabolites from "gut microbiota and host co-metabolism". All of these aim to investigate biological mechanisms and effective components of Chinese medicines based on gut microbiota and offer a new strategy for promoting safe and effective application of Chinese medicines.
本文基于肠道微生物群的生理功能,总结了近年来中药与肠道微生物群相互作用的研究进展,包括有毒/刺激性中药对肠道微生物群的失衡影响、中药对肠道微生物群失衡的预后作用、肠道微生物群对中药成分的代谢作用以及肠道微生物群与宿主之间的共代谢作用。我们将对中药的具体生物学效应、肠道微生物群结构以及“肠道微生物群与宿主共代谢”内源性代谢产物之间的关系进行思考和展望。所有这些旨在基于肠道微生物群研究中药的生物学机制和有效成分,并为促进中药安全有效应用提供新策略。